Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells by Abdul Aziz, Muhammad Yusran et al.
Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating 
p53 and p21 genes in MCF-7 breast cancer cells 
ABSTRACT 
Damnacanthal, an anthraquinone compound, is isolated from the roots of Morinda citrifolia 
L. (noni), which has been used for traditional therapy in several chronic diseases, including 
cancer. Although noni has long been consumed in Asian and Polynesian countries, the 
molecular mechanisms by which it exerts several benefits are starting to emerge. In the 
present study, the effect of damnacanthal on MCF-7 cell growth regulation was investigated. 
Treatment of MCF-7 cells with damnacanthal for 72 h indicated an antiproliferative activity. 
The MTT method confirmed that damnacanthal inhibited the growth of MCF-7 cells at the 
concentration of 8.2 µg/ml for 72 h. In addition, the drug was found to induce cell cycle 
arrest at the G1 checkpoint in MCF-7 cells by cell cycle analysis. Damnacanthal induced 
apoptosis, determined by Annexin V-fluorescein isothiocyanate/propidium iodide (PI) 
dual-labeling, acridine-orange/PI dyeing and caspase-7 expression. Furthermore, 
damnacanthal-mediated apoptosis involves the sustained activation of p21, leading to the 
transcription of p53 and the Bax gene. Overall, the present study provided significant 
evidence demonstrating that p53-mediated damnacanthal induced apoptosis through the 
activation of p21 and caspase-7. 
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